Today’s cancer therapies are hard, costly, and gradual to produce. But the blend of new computing and new organic systems is top to a much better comprehension of the human immune method, with the intention of offering a much better class of most cancers therapies.
Azeem Azhar speaks with Immunai co-founder and chief technological innovation officer Luis Voloch about how AI is unlocking the strategies of the immune process and opening new avenues for novel cancer treatment options.
They also explore:
- Why Luis and his co-founder, two equipment finding out engineers, determined to start off a bio startup.
- How Immunai utilizes solitary-mobile genomics to map out the immune process.
- The trajectory of Immunai’s experiments from the lab to the affected individual.
@Azeem
@exponentialview
@Immunaitech
Additional sources:
Scaling Artificial Biology (with Gingko’s Reshma Shetty), Exponential View Podcast, 2022
The Future of Healthcare: Personalization and AI (with ZOE’s Jonathan Wolf), Exponential See Podcast, 2022
A transcript of this episode will be offered by April 13, 2022.